270 related articles for article (PubMed ID: 30041239)
1. An Engineered DC-Targeting Lentivector Induces Robust T Cell Responses and Inhibits HBV Replication in HBV Transgenic Mice via Upregulating T Cell Autophagy.
Ma S; Chen X; Tan Q; Dai S; Li D; Wu S; Yu Y; Zang G; Tang Z
Cell Physiol Biochem; 2018; 48(3):1041-1059. PubMed ID: 30041239
[TBL] [Abstract][Full Text] [Related]
2. An engineered novel lentivector specifically transducing dendritic cells and eliciting robust HBV-specific CTL response by upregulating autophagy in T cells.
Ma S; Chen X; Tan Q; Li D; Dai S; Wu S; Yu Y; Zang G; Tang Z
Cell Cycle; 2018; 17(10):1220-1234. PubMed ID: 30019620
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Tang Z; Zang G
Cell Physiol Biochem; 2017; 41(2):423-438. PubMed ID: 28214886
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice.
Zhuo M; Song L; Tang Y; Dai S; Chen X; Yu Y; Zang G; Tang Z
Mol Med Rep; 2015 Sep; 12(3):3591-3598. PubMed ID: 26004262
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-based vaccination with lentiviral vectors encoding ubiquitinated hepatitis B core antigen enhances hepatitis B virus-specific immune responses in vivo.
Dai S; Zhuo M; Song L; Chen X; Yu Y; Tang Z; Zang G
Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):870-9. PubMed ID: 26373843
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of CTLs induced by DCs loaded with ubiquitinated hepatitis B virus core antigen.
Chen JH; Yu YS; Chen XH; Liu HH; Zang GQ; Tang ZH
World J Gastroenterol; 2012 Mar; 18(12):1319-27. PubMed ID: 22493545
[TBL] [Abstract][Full Text] [Related]
8. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice.
Chen X; Lai J; Pan Q; Tang Z; Yu Y; Zang G
Vaccine; 2010 May; 28(23):3913-9. PubMed ID: 20394723
[TBL] [Abstract][Full Text] [Related]
9. [HBcAg-specific CTL response induced by PTD-HBcAg fusion protein to inhibit HBV replication in vitro].
Chen XH; Pan QC; Yu YS; Tang ZH; Zang GQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):289-92. PubMed ID: 19351491
[TBL] [Abstract][Full Text] [Related]
10. Tapasin modification on the intracellular epitope HBcAg18-27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo.
Chen X; Tang Y; Zhang Y; Zhuo M; Tang Z; Yu Y; Zang G
Lab Invest; 2014 May; 94(5):478-90. PubMed ID: 24614195
[TBL] [Abstract][Full Text] [Related]
11. Immunization with lentiviral vector‑modified dendritic cells encoding ubiquitinated hepatitis B core antigen promotes Th1 differentiation and antiviral immunity by enhancing p38 MAPK and JNK activation in HBV transgenic mice.
Dai S; Chen X; Yu Y; Zang G; Tang Z
Mol Med Rep; 2018 Nov; 18(5):4691-4699. PubMed ID: 30221736
[TBL] [Abstract][Full Text] [Related]
12. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
13. Avasimibe can cooperate with a DC-targeting and integration-deficient lentivector to induce stronger HBV specific T cytotoxic response by regulating cholesterol metabolism.
Ma S; Lv M; Chen X; Zang G; Tang Z; Zhang Y; Hu W
Antiviral Res; 2023 Aug; 216():105662. PubMed ID: 37393054
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-modified hepatitis B virus core antigen effectively facilitates antigen presentation and enhances cytotoxic T lymphocyte activity via the cytoplasmic transduction peptide in vitro.
Song L; Zhuo M; Tang Y; Chen X; Yu Y; Tang Z; Zang G
Mol Med Rep; 2015 Jul; 12(1):289-96. PubMed ID: 25684256
[TBL] [Abstract][Full Text] [Related]
15. Role of Autophagy in the Ubiquitinated Hepatitis B Virus Core Antigen Enhancing Dendritic Cell Function.
Huang R; Chen J; Tan Q; Hu W; Chen X; Yu Y; Zang G; Tang Z
Viral Immunol; 2022 Nov; 35(9):629-639. PubMed ID: 36315216
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances HBV-specific humoral and CTL immune responses in vivo.
Song L; Zhuo M; Tang Y; Chen X; Tang Z; Zang G
Int Immunopharmacol; 2014 Nov; 23(1):1-7. PubMed ID: 25135878
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus vector encoding TPPII ignites HBV-specific CTL response by activating autophagy in CD8+ T cell.
Tan Q; Chen J; Gao G; Yizhang ; Chen X; Yu Y; Zang G; Tang Z
J Viral Hepat; 2022 Mar; 29(3):178-188. PubMed ID: 34902200
[TBL] [Abstract][Full Text] [Related]
19. HBcAg18-27 epitope fused to HIV-Tat 49-57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice.
Wang S; Han Q; Zhang N; Chen J; Liu Z; Zhang G; Li Z
Immunol Lett; 2010 Jan; 127(2):143-9. PubMed ID: 19883689
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
